Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNORE-ASA cognitive decline study in older adults with sleep apnoea screening
ACTRN12612000891820Phase 4Active, not recruiting
- Sponsor
- Monash University
- Start
- Mar 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in No canonical disease name; "cognitive deterioration" is a descriptive term, not a recognized disease entity and sleep apnea comparing Aspirin with Placebo (2 arms). Primary endpoint: Change in modified mini mental state examination. Started Mar 2012; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
No canonical disease name; "cognitive deterioration" is a descriptive term, not a recognized disease entity.sleep apnea
Beyond the preview
Go deeper on ACTRN12612000891820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000891820.